After carrying out a feasibility assessment by checking that the study meets with the initial approval of potential contributors, the CI/PI should contact the ICHT Clinical Division's research manager with a summary of the findings. The Divisional research manager will decide how to proceed with the study:
- Deemed as feasible – continue to study work-up
- Inconclusive – the Clinical Division may ask the CI/PI for further information or to re-submit the study with some changes
- Deemed as unfeasible – the proposal is rejected.
Resources
| Type | Where to find |
|---|---|
| Key contacts | Clinical Divisions |
| Useful links | NIHR Clinical Trials Toolkit - feasibility |
| NIHR benchmark | Prior to NIHR 70-day benchmark |
| Process map links | This activity occurs in the feasibility stage: > Imperial College London as sponsor > Imperial College Hospital NHS Trust as sponsor > Commercial organisation as sponsor > Non-commercial organisation as sponsor |